{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:40:22Z","timestamp":1760060422840,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR)","doi-asserted-by":"publisher","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019945","name":"Departament d\u2019Universitats, Recerca i Societat de la Informaci\u00f3 de la Generalitat de Catalunya","doi-asserted-by":"publisher","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}],"id":[{"id":"10.13039\/501100019945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 La Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIBER-Consorci\u00f3 Centro de Investigaci\u00f3n Biom\u00e9dica en Red","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}]},{"name":"Instituto de Salud Carlos III, Ministerio de Ciencia e Innovaci\u00f3n","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}]},{"name":"MCIN\/AEI\/10.13039\/501100011033","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}]},{"name":"Generalitat de Catalunya through the \u201cCERCA Program\u201d","award":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"],"award-info":[{"award-number":["PI2200536","1502-23","2021SGR01569","201816-10","CB21\/13\/0081","CEX2023-001290-S"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Objective: To analyze trends in resistance to antituberculous drugs over a 31-year period (1991\u20132022) at a hospital in Barcelona and to identify associated epidemiological determinants. Methods: This study included culture-confirmed tuberculosis cases diagnosed between 1991 and 2022. Drug susceptibility testing was conducted with clinical data from hospital records and epidemiological data from the Barcelona Public Health Agency. The primary outcome was resistance to first-line drugs. A subset of isolates was tested for second-line drugs. Trends were compared between the periods 1991\u20132000 and 2001\u20132022, aligning with increased immigration. Factors associated with resistance were examined using multivariate regression analysis. Results: Among the 2448 patients included, tuberculosis cases peaked in the 1990s and subsequently declined, while drug resistance increased. Overall, 12.2% of isolates showed resistance to at least one drug: 8.5% were monoresistant, 2.3% multiresistant, and 1.4% polyresistant. The 2001\u20132022 period had a higher resistance rate (OR 1.63; 95%CI 1.28\u20132.09) but lower multiresistance (OR 0.40; 95%CI 0.23\u20130.69). Resistance among new cases doubled from 6.4% to 12.8%, while rates among previously treated cases remained stable. The predictors of resistance were foreign-born (OR 1.52; 95%CI 1.21\u20131.91) and previous tuberculosis treatment (OR 2.88; 95%CI 2.17\u20133.81). A total of 90% of isolates remained susceptible to fluoroquinolones and aminoglycosides. Conclusions: Although tuberculosis incidence has declined over the past three decades, antibiotic resistance has increased, driven by foreign-born and retreatment cases. Ongoing drug susceptibility testing, access to second-line therapies, and targeted public health interventions for high-risk populations are essential to maintain control in low-incidence settings.<\/jats:p>","DOI":"10.3390\/antibiotics14090875","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:02:57Z","timestamp":1756825377000},"page":"875","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-1024","authenticated-orcid":false,"given":"Mateu","family":"Espasa","sequence":"first","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Pag\u00e1n","sequence":"additional","affiliation":[{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Fern\u00e1ndez-Pittol","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngels","family":"Orcau","sequence":"additional","affiliation":[{"name":"Ag\u00e8ncia de Salut P\u00fablica de Barcelona, Pl. Lesseps, 08023 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-7051","authenticated-orcid":false,"given":"Griselda","family":"Tud\u00f3","sequence":"additional","affiliation":[{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-5832","authenticated-orcid":false,"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Servei de Malalties Infeccioses, Hospital Cl\u00ednic de Barcelona, 08036 Barcelona, Spain"},{"name":"CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Medicina, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Antonio","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Servei de Malalties Infeccioses, Hospital Cl\u00ednic de Barcelona, 08036 Barcelona, Spain"},{"name":"CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Medicina, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Soler","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Medicina, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"},{"name":"Department of Pneumology, Hospital Cl\u00ednic de Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4661-5692","authenticated-orcid":false,"given":"Laura","family":"Horvath-Ruiz","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"San-Nicol\u00e1s","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Climent","family":"Casals-Pascual","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"},{"name":"CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-3926","authenticated-orcid":false,"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"},{"name":"CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-2459","authenticated-orcid":false,"given":"Juan-Pau","family":"Millet","sequence":"additional","affiliation":[{"name":"Ag\u00e8ncia de Salut P\u00fablica de Barcelona, Pl. Lesseps, 08023 Barcelona, Spain"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), 28029 Madrid, Spain"},{"name":"Tuberculosis Research Unit Foundation of Barcelona (fuiTB), 08023 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-111X","authenticated-orcid":false,"given":"Joan A.","family":"Cayl\u00e0","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Unit Foundation of Barcelona (fuiTB), 08023 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-6706","authenticated-orcid":false,"given":"Julian","family":"Gonzalez-Martin","sequence":"additional","affiliation":[{"name":"Servei de Microbiologia, CDB, Hospital Cl\u00ednic de Barcelona, c\/Villarroel 170, 08036 Barcelona, Spain"},{"name":"ISGLOBAL, Barcelona Institute for Global Health, c\/Rossell\u00f3 132, 08036 Barcelona, Spain"},{"name":"Departament de Fonaments Cl\u00ednics, Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona, c\/Casanova 143, 08036 Barcelona, Spain"},{"name":"CIBER of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021). Global Tuberculosis Report 2021, WHO."},{"key":"ref_2","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rodrigo, T., Millet, J.P., Bravo, M., Tabernero, E.M., Cayl\u00e0, J.A., Rinc\u00f3n, I.V., Pla, E.D., Remacha, M.C.M., Ib\u00e1\u00f1ez, A.F., and Dur\u00e1n, J.G. (2025). Evolution of Tuberculosis in Spain: Will the objectives of the End Tuberculosis Strategy be Achieved in Western European Countries?. Enferm. Infecc. Microbiol. Clin., in press.","DOI":"10.1016\/j.eimce.2025.02.017"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1157\/13128781","article-title":"Multidrug-resistant tuberculosis","volume":"26","author":"Alcaide","year":"2008","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.arbres.2024.08.001","article-title":"Clinical Practice Guidelines on the Management of Resistant Tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)","volume":"60","author":"Caminero","year":"2024","journal-title":"Arch. Bronconeumol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"World Health Organization (2025). WHO Consolidated Operational Handbook on Tuberculosis. Module 4: Treatment and Care, World Health Organization.","DOI":"10.2471\/B09403"},{"key":"ref_7","first-page":"493","article-title":"Drug resistance of Mycobacterium tuberculosis. Multicenter study in the Barcelona area","volume":"115","author":"Alcaide","year":"2000","journal-title":"Med. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0300-2896(15)30096-X","article-title":"Evolution of resistance to Mycobacterium tuberculosis in the province of Castell\u00f3n. Years 1992\u20131998","volume":"36","author":"Royo","year":"2000","journal-title":"Arch. Bronchopneumol."},{"key":"ref_9","first-page":"1230","article-title":"Study of Mycobacterium tuberculosis drug resistance in the region of Galicia, Spain","volume":"9","author":"Anibarro","year":"2005","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_10","first-page":"192","article-title":"Usefulness of phenotypic and genotypic methods in the study of Mycobacterium tuberculosis resistance to first-line anti-tuberculous drugs","volume":"53","year":"2017","journal-title":"Arch. Bronchopneumol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.arbres.2014.06.001","article-title":"Resistance to first-line antituberculous drugs in Spain during 2010\u20132011. RETUBES Studio","volume":"51","author":"Blanquer","year":"2015","journal-title":"Arch. Bronconeumol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: A systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid2103.141343","article-title":"Multidrug-Resistant Tuberculosis in Europe, 2010\u20132011","volume":"21","author":"Guenther","year":"2015","journal-title":"Emerg. Infect Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e7219","DOI":"10.1097\/MD.0000000000007219","article-title":"The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995\u20132013)","volume":"96","author":"Navas","year":"2017","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5588\/ijtld.15.0643","article-title":"Tuberculosis and immigration in an area of southwest Madrid","volume":"20","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_16","unstructured":"Millet, J.P., Orcau, A., L\u00f3pez-Muley, C., Molero, J., Artigas, A., Avellan\u00e9s, I., Clos, R., Collado, L., de Andr\u00e9s, A., and Forns, M.L. (2024). La Tuberculosi A Barcelona. Informe 2022, Ag\u00e8ncia de Salut P\u00fablica de Barcelona. Available online: https:\/\/www.aspb.cat\/wp-content\/uploads\/2020\/10\/ASPB-Tuberculosi-Barcelona-2022-cast_241106.pdf."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cayl\u00e0, J.A., and Orcau, A. (2011). Control of tuberculosis in large cities in developed countries: An organizational problem. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-127"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Minion, J., Gallant, V., Wolfe, J., Jamieson, F., and Long, R. (2013). Multidrug and Extensively Drug-resistant Tuberculosis in Canada 1997\u20132008: Demographic and Disease Characteristics. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053466"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: A systematic review","volume":"61","author":"Faustini","year":"2006","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Suchindran, S., Brouwer, E.S., and Van Rie, A. (2009). Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005561"},{"key":"ref_21","unstructured":"World Health Organization (2018). Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis, WHO."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2024.11.014","article-title":"Association between the rifampicin resistance mutations and rifabutin susceptibility in Mycobacterium tuberculosis: A meta-analysis","volume":"40","author":"Wang","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.01030-10","article-title":"Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Brossier","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/lungindia.lungindia_120_21","article-title":"Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis","volume":"38","author":"Sarin","year":"2021","journal-title":"Lung India"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, Y., Yuan, Z., Shen, X., Wu, J., Wu, Z., and Xu, B. (2016). Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai. Biomed. Res. Int., 2016.","DOI":"10.1155\/2016\/2628913"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ccm.2019.08.002","article-title":"Treatment of Drug-Resistant Tuberculosis","volume":"40","author":"Mase","year":"2019","journal-title":"Clin. Chest Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/JCM.02162-06","article-title":"Multicenter laboratory evaluation of the MB\/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis","volume":"45","author":"Alcaide","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","article-title":"Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials","volume":"44","author":"Pfyffer","year":"2006","journal-title":"J. Clin. Microbiol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/9\/875\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:58Z","timestamp":1760034958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/9\/875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["antibiotics14090875"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14090875","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}